Physician and Patient Perception of Adjustable Maintenance Dosing of Symbicort Turbuhaler 
      This study will evaluate the perception of the physicians and the patients about the approved
      adjustable dosing of SymbicortÂ® 160/4,5. Symbicort maintenance dose will be adjusted up and
      down within the approved dose range of 1x2 - 4x2 inhalations per day, to the level of asthma
      symptoms. Patients and physicians perception of this new dosing schedule will be evaluated by
      means of questionnaires completion and direct questioning.
     Perception of Physicians & Patients of AMD :

          -  Minimum of 6 months history of asthma and treatment with an inhaled corticosteroids
             for at least 3 months prior to visit 1 and/or a history of short term variation in
             airway function and asthma symptoms responding promptly to convent

          -  Patients where use of a combination (inhaled corticosteroid and long acting
             beta2-agonist is appropriate, i.e. not controlled on inhaled corticosteroids alone).

         :

          -  Asthma exacerbation requiring oral corticosteroid treatment in the four weeks prior to
             visit 1

          -  Upper Respiratory Tract Infection in the previous four weeks

          -  Severe cardiovascular disease or other significant concomitant disease, which may
             interfere with the conduct of the study.

          -  Women enrolled in the trial should not be planning pregnancy and should be taking
             adequate contraceptive measures where appropriate.

          -  Previous enrollment in a clinical study

          -  Known or suspected hypersensitivity to budesonide, formoterol or inhaled lactose
      